Author:
Gueret Pierre,Combe S.,Krezel C.,Fuseau E.,van Giersbergen P. L. M.,Petitou M.,Neuhart E.
Funder
Endotis Pharma, Romainville, France
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine
Reference15 articles.
1. Olson ST, Swanson R, Petitou M (2012) Specificity and selectivity profile of EP217609: a new, neutralizable, dual-action anticoagulant that targets thrombin and factor Xa. Blood 119(10):2187–2195
2. Petitou M, Nancy-Portebois V, Dubreucq G, Motte V, Meuleman D, de Kort M, van Boeckel CAA, Vogel GMT, Wisse JAJ (2009) From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. Thromb Haemost 102:804–810
3. Buijsman RC, Basten JEM, van Dinther TG, van der Marel GA, van Boeckel CAA, van Boom JH (1999) Design and synthesis of a novel synthetic NAPAP-pentasaccharide conjugate displaying dual antithrombotic action. Bioorg Med Chem Lett 9:13–18
4. Vogel GMT, Meuleman DG, van Dinther TG, Buijsman R, Princen AWM, Smit MJ (2003) Antithrombotic properties of a direct thrombin inhibitor with a prolonged half-life and AT-mediated factor Xa inhibitory activity. J Thromb Haemost 1:1945–1954
5. Amiral J, Kerbarh O, Krezel C, Neuhart E, Petitou M (2011) Stability of the biotin moiety in EP217609, a new parenteral anticoagulant neutralizable by avidin. J Thromb Haemost 9(Suppl. 2):1–970 abstract P-TH- 165
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献